I strive to gain a full understanding of my clients’ needs and find a creative solution that meets their requirements.
Ikuo leads origination and execution of mergers and acquisitions (M&A) transactions for domestic and international companies. During his nearly 35-year investment banking career, Ikuo has worked on a wide range of deals including acquisitions, divestitures, public tenders and restructurings, as well as debt and equity capital market transactions. He has completed numerous cross-border transactions involving large corporations.
Ikuo supports Japan-based companies who have an appetite to expand internationally, and Japanese industry segments looking to consolidate. He has advised across multiple industries, with a specific emphasis on chemicals and healthcare sectors.
Prior to joining Lincoln, Ikuo was a managing director at KPMG, where he led the firm’s M&A advisory efforts in Japan. Previously, Ikuo worked in the investment banking divisions of Salomon Brothers, Lehman Brothers, Barclays and BNP Paribas in New York, Tokyo and London. Ikuo began his career at the Ministry of Finance of Japan.
Ikuo earned a Master of Business Administration degree from Stanford University and a Bachelor of Laws degree from the University of Tokyo.
Lincoln International represents Sekisui Medical Co., Ltd, Sekisui Chemical Co., Ltd. in the sale of Sekisui Virotech GmbH to Virotech Diagnostics Holdings GmbH
Lincoln International represents nolax AG in the sale of its airbag coatings business to Japanese Nitto Denko Corporation
Lincoln International represents Baylor College of Medicine in the announced transaction between Medical Genetics Laboratories and Miraca Holdings Inc.
Perspectives by Ikuo Mori
Q&A: The Evolution of Medtech in a Globalizing Industry
View original post from Pitchbook on May 29, 2019 here. […]
Meet our Senior Team
Building long-term relationships is key for me personally – I want to be the advisor of trust for my clients.
Managing Director | CEO GermanyFrankfurt